The US Food and Drug Administration (FDA) has approved Yuvezzi (carbachol and brimonidine tartrate ophthalmic solution) 2.75% ...
UK-based Tenpoint Therapeutics and Seattle’s Visus Therapeutics have announced the completion of their merger to create an entirely new chapter in ophthalmic therapeutic medicines aimed at ...
Unele rezultate au fost ascunse, deoarece pot fi inaccesibile pentru dvs.
Afișați rezultatele inaccesibile